Teva to Repay $1.2B for Cephalon’s Conspiring with Generic Firms

  ( – The Federal Trade Commission said Thursday that Teva Pharmaceutical Industries Ltd., now the parent company of Cephalon, agreed to repay $1.2 billion in “ill-gotten gains” for pay-to-delay deals when the two companies were competitors. The settlement came as a trial was set Read More